Thalomid
information and resources from the National Cancer Institute
NCI Thesaurus | Thalomid
(Other name for: thalidomide)NCI Thesaurus | Thalomid
(Other name for: thalidomide)
|
|
|
|
news articles
Cancer patient to get free drug 01 Apr 2006
Globe and Mail, ...old multiple myeloma patient who was denied access to a free drug because a $35,000 licensed alternative was available will be able to obtain Thalomid to treat ...
Thalomid With Chemotherapy Helps Older Myeloma Patients Mar 10, 2006
MedPage Today, TURIN, Italy, March 10 - A second study in less than a week has found that Thalomid (thalidomide) has a place in first-line therapy for multiple myeloma ...
No Survival Advantage for Thalomid in Multiple Myeloma Mar 9, 2006
MedPage Today, LITTLE ROCK, Ark., March 9 - The addition of Thalomid (thalidomide) to high-dose chemotherapy for multiple myeloma led to improved complete responses and event ...
Thalomid® and IL-2 Effective for Metastatic Renal Cell Carcinoma Mar 20, 2006
Cancer Consultants (press release), Hospital in Houston, Texas, have reported that treatment of metastatic renal cell carcinoma (MRCC) with interleukin-2 (IL-2) and Thalomid (thalidomide) results ...
Temodar® and Thalomid® Effective for Metastatic Neuroendocrine ... Mar 21, 2006
Cancer Consultants (press release), Researchers from the Dana-Farber Cancer Center have reported that the oral administration of Temodar (temozolomide) and Thalomid (thalidomide) in patients with ...
Temodar® and Thalomid® Effective for Advanced Neuroendocrine ... Mar 20, 2006
Cancer Consultants (press release), ...recently published in the Journal of Clinical Oncology, the treatment combination consisting of Temodar® (temozolomide) and Thalomid® (thalidomide) is ...
Thalomid® in Induction Improves Response Rates in Elderly with ... Mar 14, 2006
Cancer Consultants (press release), An Italian multicenter randomized trial has determined that elderly patients with multiple myeloma treated with Thalomid (thalidomide) in addition to melphalan ...
Why use free drug when you can pay $35,000? Mar 22, 2006
Globe and Mail, But Health Canada won't release Thalomid to him because a licensed alternative is available -- it just happens to come with a $35,000 price tag. ...
Why let a dying man have free drug when he could pay $35,000? Mar 22, 2006
Globe and Mail, But Health Canada won't release Thalomid to him because a licensed alternative is available — it just happens to come with a $35,000 price tag. ...
Ottawa's stand on drugs 'completely unacceptable' Mar 23, 2006
Globe and Mail, Health Canada recently decided to stop authorizing under its special access program the drug thalidomide, known by the trade name Thalomid, for multiple ...
DYING MAN DENIED FREE DRUG Mar 22, 2006
Free Market News Network, But Health Canada won't release Thalomid to him because a licensed alternative is available - it just happens to come with a $35,000 price tag. ...
Thalidomide and IL-2 Effective for Metastatic Renal Cell Carcinoma Mar 20, 2006
Cancer Consultants (press release), According to an article recently published in the journal Cancer, the treatment combination consisting of thalidomide (Thalomid®) and interleukin-2 (IL-2 ...
��：生命�纬 Mar 20, 2006
BioX, The 20-year-old company became profitable just three years ago as it honed the development and marketing of its cancer drug Thalomid, which has become the ...
Thalidomide shows promise for ALS Mar 11, 2006
Monsters and Critics.com, Kiaei said. The study appears in the Journal of Neuroscience and involved both Celgene`s Thalomid (thalidomide) and Revlimid. He ...
Update 1: Drug Stops Working in Myeloma Patients Mar 8, 2006
Forbes Medicine. It was paid for by Celgene Corp., maker of the Thalomid brand of thalidomide, and the National Cancer Institute. Thalidomide ...
Drug fails in cancer study Mar 12, 2006
Indianapolis Star, The study, paid for by Celgene Corp., maker of the Thalomid brand of thalidomide, and the National Cancer Institute, was reported in this past week's New ...
Millennium CEO says may form strategic partnership Mar 10, 2006
Reuters Revlimid is in the same class of drugs -- known as IMiDs -- as Thalomid, a Celgene drug that is approved to treat leprosy but mainly prescribed to treat ...
New Doubts On Thalidomide As Cancer Fighter Mar 9, 2006
All Headline News ...of Medicine. It was paid for by Celgene, maker of the Thalomid brand of thalidomide, and the National Cancer Institute. According ...
Drug Stops Working in Myeloma Patients Mar 8, 2006
Olberlin, It was paid for by Celgene Corp., maker of the Thalomid brand of thalidomide, and the National Cancer Institute . Celgene‘s Thalomid ...
New cancer studies indicate no benefit from thalidomide Mar 8, 2006
Newark Star Ledger, It was paid for by Celgene Corp., of Summit, NJ, maker of the Thalomid brand of thalidomide, and the National Cancer Institute. ...
Three Maryland Biotechs Reveal Losses in Their Annual Reports Mar 16, 2006
International News Service, ...the $514,000 in sales for the year before.The revenue increase, company officials said, is due in part to royalty payments from sales of Thalomid, a product ...
Doxil® in the VAD Regimen for Myeloma Confirmed Less Toxic Than ... Feb 28, 2006
Cancer Consultants (press release), However, recent induction regimens have incorporated newer drugs such as Thalomid® (thalidomide), Revlimid® (lenalidomide), and Velcade® (bortezomib). ...
Study: Drug Aids Older Myeloma Patients Mar 9, 2006
Washington Post, It licensed rights to sell it in several countries from Celgene Corp. of Summit, NJ, which sells it in the United States as Thalomid. ...
EntreMed Reports Fourth Quarter and Year-End 2005 Financial ... Mar 7, 2006
PR Newswire (press release), Dane R. Saglio, EntreMed Chief Financial Officer, commented, "Fourth quarter royalty revenues, based on Celgene sales of Thalomid(R), offset a portion of our ...
107 Abstracts on Clinical Data Evaluating REVLIMID(R) and ... Dec 8, 2005
PR Newswire (press release), Safety Notice THALOMID(R) (thalidomide) Capsules 50 mg, 100 mg, & 200 mg If thalidomide is taken during pregnancy, it can cause severe birth defects or death ...
Celgene's Revlimid Revelation Dec 11, 2005
TheStreet.com Thalidomide, sold by Celgene under the brand name Thalomid, is currently approved to treat leprosy but is more often prescribed by doctors to treat multiple ...
GlycoGenesys, Inc. GCS-100 Cancer Drug Candidate Subject of ... Dec 15, 2005
Genetic Engineering News, ...cell death in multiple myeloma patient cells, including those refractory to traditional chemotherapies such as dexamethasone, Velcade(R), and Thalomid(R). ...
Celgene Seen As 'Key Portfolio Holding' In Biotech Dec 12, 2005
Forbes ...various cancers of the blood, Zhong said. Revlimid is a follow-on to the company's drug Thalomid. On Sunday, at the annual meeting ...
107 Abstracts on Clinical Data Evaluating REVLIMID(R) and ... Dec 8, 2005
PR Newswire (press release), THALOMID (thalidomide), manufactured by Celgene Corporation, received US Food and Drug Administration (FDA) clearance on July 16, 1998 for the acute treatment ...
Are safety labeling and safety warnings enough? Nov 23, 2005
Naples Sun Times, Interestingly enough, it recently returned to the market as Thalomid and is used to treat leprosy and multiple myeloma. Thalomid ...
|
|
